Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation.

Sabina Bijlsma; Ivana Bobeldijk; Elwin R Verheij; Raymond Ramaker; Sunil Kochhar; Ian A Macdonald; Ben van Ommen; Age K Smilde

doi:10.1021/ac051495j

Home/Archive/PubMed

PubMed · 16408941

Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation.

Sabina Bijlsma·Ivana Bobeldijk·Elwin R Verheij·Raymond Ramaker·Sunil Kochhar·Ian A Macdonald·Ben van Ommen·Age K Smilde

View original source ↗Export metadata ↓

Abstract

A large metabolomics study was performed on 600 plasma samples taken at four time points before and after a single intake of a high fat test meal by obese and lean subjects. All samples were analyzed by a liquid chromatography-mass spectrometry (LC-MS) lipidomic method for metabolic profiling. A pragmatic approach combining several well-established statistical methods was developed for processing this large data set in order to detect small differences in metabolic profiles in combination with a large biological variation. Such metabolomics studies require a careful analytical and statistical protocol. The strategy included data preprocessing, data analysis, and validation of statistical models. After several data preprocessing steps, partial least-squares discriminant analysis (PLS-DA) was used for finding biomarkers. To validate the found biomarkers statistically, the PLS-DA models were validated by means of a permutation test, biomarker models, and noninformative models. Univariate plots of potential biomarkers were used to obtain insight in up- or downregulation. The strategy proposed proved to be applicable for dealing with large-scale human metabolomics studies.

Explore related subjects

Chromatography, Liquid Data Interpretation, Statistical Dietary Fats Europe Humans Least-Squares Analysis Lipids Mass Spectrometry Obesity Postprandial Period Journal Article Multicenter Study

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Sabina Bijlsma, Ivana Bobeldijk, Elwin R Verheij, Raymond Ramaker, Sunil Kochhar, Ian A Macdonald, Ben van Ommen, Age K Smilde. 2006-01-15. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation.. https://doi.org/10.1021/ac051495j

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Mass balance assessment of triclosan removal during conventional sewage treatment.

The antimicrobial agent triclosan (5-chloro-2-(2,4-dichlorophenoxy)phenol; TCS) is a member of a larger group of polychlorinated binuclear aromatic compounds frequently associated with adverse environmental and human health effects. Whereas the structure and function of TCS would suggest significant resistance to biotransformation, biological wastewater treatment currently is considered the principal destructive mechanism limiting dispersal of and environmental contamination with this compound. We explored the persistence of TCS in a typical full-scale activated sludge US sewage treatment plant using a mass balance approach in conjunction with isotope dilution liquid chromatography electrospray ionization mass spectrometry (ID-LC-ESI-MS) for accurate quantification. Average influent and effluent concentrations (mean +/- SD) of 4.7+/-1.6 and 0.07+/-0.06 microg 1(-1), respectively, revealed an apparent (liquid-phase) removal efficiency of 98+/-1%. However, further analyses demonstrated that the particle-active TCS (80+/-22% particle-associated in influent) was sequestered into wastewater residuals and accumulated in dewatered, digested sludge to concentrations of 30000+/-11000 microg kg-1. Overall, 50+/-19% (1640+/-610 g d-1) of the disinfectant mass entering the plant (3240+/-1860 g d-1) remained detectable in sludge, and less than half of the total mass (48+/-19%) was biotransformed or lost to other mechanisms. Thus, conventional sewage treatment was demonstrated to be much less effective in destroying the antimicrobial than the aqueous-phase removal efficiency of the plant would make believe. Furthermore, study findings indicate that the common practice of sludge recycling in agriculture results in the transfer of substantial quantities of TCS to US soils used, in part, for animal husbandry and crop production.

Chromatography, Liquid↗

PubMed2006

Production of glutathione sulfonamide and dehydroglutathione from GSH by myeloperoxidase-derived oxidants and detection using a novel LC-MS/MS method.

GSH is rapidly oxidized by HOCl (hypochlorous acid), which is produced physiologically by the neutrophil enzyme myeloperoxidase. It is converted into, mainly, oxidized glutathione. Glutathione sulfonamide is an additional product that is proposed to be covalently bonded between the cysteinyl thiol and amino group of the gamma-glutamyl residue of GSH. We have developed a sensitive liquid chromatography-tandem MS assay for the detection and quantification of glutathione sulfonamide as well as GSH and GSSG. The assay was used to determine whether glutathione sulfonamide is a major product of the reaction between GSH and HOCl, and whether it is formed by other two-electron oxidants. At sub-stoichiometric ratios of HOCl to GSH, glutathione sulfonamide accounted for up to 32% of the GSH that was oxidized. It was also formed when HOCl was generated by myeloperoxidase and its yield increased with the flux of oxidant. Of the other oxidants tested, only hypobromous acid and peroxynitrite produced substantial amounts of glutathione sulfonamide, but much less than with HOCl. Chloramines were able to generate detectable levels only when at a stoichiometric excess over GSH. We conclude that glutathione sulfonamide is sufficiently selective for HOCl to be useful as a biomarker for myeloperoxidase activity in biological systems. We have also identified a novel oxidation product of GSH with a molecular weight two mass units less than GSH, which we have consequently named dehydroglutathione. Dehydroglutathione represented a few percent of the total products and was formed with all of the oxidants except H2O2.

Chromatography, Liquid↗

PubMed2006

A novel SET domain methyltransferase in yeast: Rkm2-dependent trimethylation of ribosomal protein L12ab at lysine 10.

The ribosomal protein L12ab (Rpl12ab) in Saccharomyces cerevisiae is modified by methylation at both arginine and lysine residues. Although the enzyme responsible for the modification reaction at arginine 66 has been identified (Rmt2), the enzyme(s) responsible for the lysine modification(s) has not been found, and the site(s) of methylation has not been determined. Here we demonstrate, using a combination of mass spectrometry and labeling assays, that the yeast gene YDR198c encodes the enzyme responsible for the predominant epsilon-trimethylation at lysine 10 in Rpl12ab. An additional site of predominant epsilon-dimethylation is observed at lysine 3; the enzyme catalyzing this modification is not known. The YDR198c gene encodes a SET domain similar to that of the Rkm1 enzyme responsible for modifying Rpl23ab, and we have now designated the YDR198c gene product as Rkm2 (ribosomal lysine methyltransferase 2). The effect of the loss of the enzyme on ribosomal complex stability was studied by polysomal fractionation. However, no difference was observed between the Deltarkm2 deletion strain and its parent wild type strain. With the identification of this enzyme, it appears that the 12 SET domain family members in yeast can now be divided into two subfamilies based on function and amino acid sequence identity. One branch includes enzymes that modify histones, including Set1 and Set2; the other branch includes Rkm1, Rkm2, and Ctm1, the cytochrome c methyltransferase. These studies suggest that the remaining seven SET domain proteins may also be lysine methyltransferases.

Chromatography, Liquid↗